Hedge Fund Filings: After-Market 13D Watch
2) James Roumell and Roumell Asset Management, whom we track, owns shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Ancora Advisors Frederick Disanto | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$18.01 | 1,900 | Director | 1,900 | 2017-11-27 | Filing | |
$18.01 | 10,125 | Director | 74,524 | 2017-11-27 | Filing | |
$18.05 | 1,300 | Director | 83,666 | 2017-12-01 | Filing | |
$18.01 | 10,125 | Director | 82,366 | 2017-11-27 | Filing | |
$17.93 | 350 | Director | 6,000 | 2017-11-03 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$17.15 | 501 | Officer | 3,100 | 2017-08-30 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 46,685 | $1,120,440 | 0.35% |